Literature DB >> 30826101

Current quality reporting methods are not adequate for salvage cardiac operations.

William Z Chancellor1, J Hunter Mehaffey2, Jared P Beller1, Elizabeth D Krebs1, Robert B Hawkins2, Kenan Yount1, Clifford E Fonner3, Alan M Speir4, Mohammed A Quader5, Jeffrey B Rich3, Leora T Yarboro1, Nicholas R Teman1, Gorav Ailawadi6.   

Abstract

OBJECTIVES: Outcomes in cardiac surgery are benchmarked against national Society of Thoracic Surgeons (STS) data and include patients undergoing elective, urgent, emergent, and salvage operations. This practice relies on accurate risk adjustment to avoid risk-averse behavior. We hypothesize that the STS risk calculator does not adequately characterize the risk of salvage operations because of their heterogeneity and infrequent occurrence.
METHODS: Data on all cardiac surgery patients with an STS predicted risk score (2002-2017) were extracted from a regional database of 19 cardiac surgery centers. Patients were stratified according to operative status for univariate analysis. Observed-to-expected (O:E) ratios for mortality and composite morbidity/mortality were calculated and compared among elective, urgent, emergent, and salvage patients.
RESULTS: A total of 76,498 patients met inclusion criteria. The O:E mortality ratios for elective, urgent, and emergent cases were 0.96, 0.98, and 0.93, respectively (all P values > .05). However, mortality rate was significantly higher than expected for salvage patients (O:E ratio, 1.41; P = .04). Composite morbidity/mortality rate was lower than expected in elective (O:E ratio, 0.81; P = .0001) and urgent (O:E ratio, 0.93; P = .0001) cases but higher for emergent (O:E ratio, 1.13; P = .0006) and salvage (O:E ratio, 1.24; P = .01). O:E ratios for salvage mortality were highly variable among each of the 19 centers.
CONCLUSIONS: The current STS risk models do not adequately predict outcomes for salvage cardiac surgery patients. On the basis of these results, we recommend more detailed reporting of salvage outcomes to avoid risk aversion in these potentially life-saving operations.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  public reporting; risk aversion; risk modeling

Year:  2019        PMID: 30826101      PMCID: PMC6660423          DOI: 10.1016/j.jtcvs.2019.01.060

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  30 in total

1.  The society of thoracic surgeons 30-day predicted risk of mortality score also predicts long-term survival.

Authors:  John D Puskas; Patrick D Kilgo; Vinod H Thourani; Omar M Lattouf; Edward Chen; J David Vega; William Cooper; Robert A Guyton; Michael Halkos
Journal:  Ann Thorac Surg       Date:  2011-10-13       Impact factor: 4.330

2.  Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection.

Authors:  David M Shahian; Fred H Edwards; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Sean M O'Brien; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

3.  Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating.

Authors:  Sean M O'Brien; David M Shahian; Elizabeth R DeLong; Sharon-Lise T Normand; Fred H Edwards; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Cynthia M Shewan; Rachel S Dokholyan; Richard P Anderson; Eric D Peterson
Journal:  Ann Thorac Surg       Date:  2007-04       Impact factor: 4.330

4.  Assessment of coronary artery bypass graft surgery performance in New York. Is there a bias against taking high-risk patients?

Authors:  E L Hannan; A L Siu; D Kumar; M Racz; D B Pryor; M R Chassin
Journal:  Med Care       Date:  1997-01       Impact factor: 2.983

5.  The impact of high-risk cases on hospitals' risk-adjusted coronary artery bypass grafting mortality rankings.

Authors:  Brian R Englum; Paramita Saha-Chaudhuri; David M Shahian; Sean M O'Brien; J Matthew Brennan; Fred H Edwards; Eric D Peterson
Journal:  Ann Thorac Surg       Date:  2015-01-09       Impact factor: 4.330

6.  Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction.

Authors:  Stephen W Waldo; James M McCabe; Cashel O'Brien; Kevin F Kennedy; Karen E Joynt; Robert W Yeh
Journal:  J Am Coll Cardiol       Date:  2015-03-24       Impact factor: 24.094

7.  The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings.

Authors:  Matthew W Sherwood; J Matthew Brennan; Kalon K Ho; Frederick A Masoudi; John C Messenger; W Douglas Weaver; David Dai; Eric D Peterson
Journal:  JACC Cardiovasc Interv       Date:  2014-12-10       Impact factor: 11.195

8.  Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York.

Authors:  James M McCabe; Stephen W Waldo; Kevin F Kennedy; Robert W Yeh
Journal:  JAMA Cardiol       Date:  2016-09-01       Impact factor: 14.676

9.  Outcome in Patients Having Salvage Coronary Artery Bypass Grafting.

Authors:  Giuseppe Santarpino; Vito G Ruggieri; Giovanni Mariscalco; Karl Bounader; Cesare Beghi; Theodor Fischlein; Francesco Onorati; Giuseppe Faggian; Giuseppe Gatti; Aniello Pappalardo; Marisa De Feo; Ciro Bancone; Andrea Perrotti; Sidney Chocron; Magnus Dalen; Peter Svenarud; Antonino S Rubino; Carmelo Mignosa; Riccardo Gherli; Francesco Musumeci; Angelo M Dell'Aquila; Eeva-Maija Kinnunen; Fausto Biancari
Journal:  Am J Cardiol       Date:  2015-07-29       Impact factor: 2.778

10.  The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock.

Authors:  Grégoire Muller; Erwan Flecher; Guillaume Lebreton; Charles-Edouard Luyt; Jean-Louis Trouillet; Nicolas Bréchot; Matthieu Schmidt; Ciro Mastroianni; Jean Chastre; Pascal Leprince; Amedeo Anselmi; Alain Combes
Journal:  Intensive Care Med       Date:  2016-01-29       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.